Novel Pharmacotherapies and NCCN Guideline Recommendations

Panelists discuss the questions below in this video.

• Up until a few years ago, there were no-FDA approved therapies for desmoid tumors. What was the role of chemotherapy and other pharmacotherapies like tyrosine kinase inhibitors in these patients? What is their role in current practice?
• What are the current NCCN guideline recommendations for treating desmoid tumors in patients?
• How do you utilize these in your daily practice?
• NCCN looks at surgery as a less preferred option vs. medication. How can this be incorporated into clinical practice, especially across specialties?